LEAH BROWN: Open Payments
NPI 1932618402 · FORT MORGAN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 13 payments from 7 companies in 2025. Trend: 2023 $206 · 2024 $1,080 · 2025 $1,498
Food & beverage: $1,498
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $382 |
| Otsuka America Pharmaceutical, Inc. | 3 | $374 |
| ABBVIE INC. | 2 | $244 |
| Amgen Inc. | 1 | $137 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| E.R. Squibb & Sons, L.L.C. | 1 | $115 |
Products named: LYBALVI, ABILIFY MAINTENA, VRAYLAR, OTEZLA, ARISTADA, INGREZZA, CAPLYTA, COBENFY.
Industry payments across CO — which companies pay providers there.
